Sukanthini Thurairatnam1. Show Affiliations » 1. Molecular Innovative Therapeutics, Sanofi Pharmaceuticals, Bridgewater, NJ, USA.
Abstract
Entities: Gene
Mesh: See more » Alzheimer Disease/drug therapyAnimalsAsthma/drug therapyDermatitis, Atopic/drug therapyDrug DesignEnzyme Inhibitors/chemistryEnzyme Inhibitors/pharmacologyEnzyme Inhibitors/therapeutic useHumansIntramolecular Oxidoreductases/antagonists & inhibitorsIntramolecular Oxidoreductases/chemistryIntramolecular Oxidoreductases/metabolismLeukodystrophy, Globoid Cell/drug therapyLipocalins/antagonists & inhibitorsLipocalins/chemistryLipocalins/metabolismMuscular Dystrophies/drug therapyNiacinamide/analogs & derivativesNiacinamide/chemistryPiperidines/chemistryPulmonary Disease, Chronic Obstructive/drug therapyPyrazoles/chemistryPyrimidines/chemistryRhinitis, Allergic, Perennial/drug therapySpinal Cord Injuries/drug therapyThiazoles/chemistry
Substances: See more » Enzyme InhibitorsLipocalinsPiperidinesPyrazolesPyrimidinesThiazolesNiacinamideIntramolecular Oxidoreductasesprostaglandin R2 D-isomerasepyrimidine
Year: 2012 PMID: 22520473 DOI: 10.1016/B978-0-12-396493-9.00004-2
Source DB: PubMed Journal: Prog Med Chem ISSN: 0079-6468